Published in Clin Biochem on October 01, 1995
A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981) 69.83
Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell (1986) 8.87
The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell (1985) 7.45
Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science (2003) 6.35
Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature (1995) 6.16
Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors. Cell (2000) 4.51
Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature (1985) 3.75
The fermentation process in tea manufacture: Tea tannin and its fermentation products. Biochem J (1939) 3.61
The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet (1995) 3.41
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res (1997) 3.38
The secondary oxidation of amino-acids by the catechol oxidase of belladonna. Biochem J (1948) 3.01
Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature (2001) 2.84
The respiration and anaerobic fermentation of tea leaf and their relationship to tea fermentation. Biochem J (1940) 2.63
Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol (1996) 2.35
Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr (2000) 2.11
Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma. Proc Natl Acad Sci U S A (2007) 2.10
Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer (2010) 2.07
Excess zinc associated with severe progressive cholestasis in Cree and Ojibwa-Cree children. Lancet (1996) 2.04
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. N Engl J Med (1990) 1.91
Methods for the volumetric estimation of tea tannin in green-leaf and black tea. A new alkaline permanganate method. Biochem J (1940) 1.88
Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol (1989) 1.78
Improving prevention systems in primary care practices: the Health Education and Research Trial (HEART) J Fam Pract (2000) 1.78
Hepatic abscess and cystic fibrosis. Postgrad Med J (1988) 1.77
Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med (1989) 1.77
Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages. J Bacteriol (2000) 1.73
Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70
Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1985) 1.66
Nerve growth cones isolated from fetal rat brain: subcellular fractionation and characterization. Cell (1983) 1.62
Defective kinesin heavy chain behavior in mouse kinesin light chain mutants. J Cell Biol (1999) 1.62
Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res (1996) 1.57
Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo(a)pyrene. Cancer Res (1987) 1.54
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med (1997) 1.51
Arbor 3D: an interactive environment for examining phylogenetic and taxonomic trees in multiple dimensions. Bioinformatics (2000) 1.50
Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut (1980) 1.50
Use of high-fat formula for premature infants with bronchopulmonary dysplasia: metabolic, pulmonary, and nutritional studies. J Pediatr (1994) 1.50
Acute pancreatitis in childhood. J Pediatr (1988) 1.49
Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr (1999) 1.47
Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut (2003) 1.45
A position paper of the North American Society for Pediatric Gastroenterology and Nutrition. Pediatric gastroenterology Workforce Survey and future supply and demand. J Pediatr Gastroenterol Nutr (1998) 1.45
Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption. Gut (1986) 1.44
Organic acids interfere in the measurement of carbon dioxide concentration by the Kodak Ektachem 700. Ann Clin Biochem (1992) 1.39
Carbamazepine interference with an immune assay for tricyclic antidepressants in plasma. J Toxicol Clin Toxicol (1998) 1.39
Effect of multiple-dose activated charcoal on the clearance of high-dose intravenous aspirin in a porcine model. Ann Emerg Med (1995) 1.38
The regulatory role of known tyrosine autophosphorylation sites of the insulin receptor kinase domain. An assessment by replacement with neutral and negatively charged amino acids. J Biol Chem (1991) 1.35
Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res (1986) 1.34
Mother-to-infant transmission of hepatitis C virus. Hepatology (2001) 1.32
High-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics (1989) 1.30
Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays. Clin Chim Acta (2004) 1.30
Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr (1985) 1.30
Autophosphorylation activates the soluble cytoplasmic domain of the insulin receptor in an intermolecular reaction. J Biol Chem (1989) 1.30
Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr (1999) 1.28
Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution. Lancet (1986) 1.28
Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med (1998) 1.28
Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet (2004) 1.27
Evidence for a primary defect of pancreatic HCO3-secretion in cystic fibrosis. Pediatr Res (1982) 1.26
Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr (1998) 1.26
Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology (1996) 1.25
A MICROCHEMICAL EXAMINATION OF McINTOSH APPLE LEAVES SHOWING RELATIONSHIP OF CELL WALL CONSTITUENTS TO PENETRATION OF SPRAY SOLUTIONS. Plant Physiol (1948) 1.24
Haplotype studies in Wilson disease. Am J Hum Genet (1994) 1.23
Mechanisms of receptor-mediated transmembrane communication. Cold Spring Harb Symp Quant Biol (1986) 1.22
Severe hepatic Wilson's disease in preschool-aged children. J Pediatr (2000) 1.22
Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology (1998) 1.22
Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet (2001) 1.21
Ranitidine kinetics and dynamics. I. Oral dose studies. Clin Pharmacol Ther (1981) 1.20
Evidence for insulin-dependent activation of S6 and microtubule-associated protein-2 kinases via a human insulin receptor/v-ros hybrid. J Biol Chem (1990) 1.19
Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology (1984) 1.17
Effect of some preslaughter treatments on the Salmonella population in the bovine rumen and faeces. J Appl Bacteriol (1968) 1.17
Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain. J Biol Chem (1995) 1.17
Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr (1995) 1.16
Haplotypes and mutations in Wilson disease. Am J Hum Genet (1995) 1.16
Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest (1989) 1.15
Dietary intakes of young children with cystic fibrosis: is there a difference? J Pediatr Gastroenterol Nutr (1996) 1.12
Late gastrointestinal bleeding and protein loss after distal small-bowel resection in infancy. J Pediatr Gastroenterol Nutr (1989) 1.11
Measurement of amphotericin B in serum or plasma by high-performance liquid chromatography. J Chromatogr (1983) 1.10
Liver disease in neonatal lupus erythematosus. J Pediatr (1990) 1.10
Spontaneous clearance of childhood hepatitis C virus infection. J Viral Hepat (2007) 1.09
Nerve growth cones isolated from fetal rat brain. IV. Preparation of a membrane subfraction and identification of a membrane glycoprotein expressed on sprouting neurons. J Cell Biol (1985) 1.08
Indomethacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr (1979) 1.07
Morbidity after percutaneous liver biopsy. Arch Dis Child (1987) 1.06
Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225. J Nucl Med (2001) 1.06
Characterization of insulin-stimulated protein serine/threonine kinases in CHO cells expressing human insulin receptors with point and deletion mutations. Biochem J (1992) 1.06
Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer. Clin Cancer Res (2001) 1.06
Heterologous transmembrane signaling by a human insulin receptor-v-ros hybrid in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1987) 1.05
Nerve growth cones isolated from fetal rat brain. III. Calcium-dependent protein phosphorylation. J Neurosci (1985) 1.05
Malnutrition: a cause of elevated sweat chloride concentration. Acta Paediatr Scand (1986) 1.03
Dietary and physical activity patterns in children with fatty liver. Eur J Clin Nutr (2010) 1.03
Meconium ileus in the absence of cystic fibrosis. Arch Dis Child (1992) 1.03
Lavage treatment of distal intestinal obstruction syndrome in children with cystic fibrosis. Pediatrics (1989) 1.02
Allelic association and linkage studies in Wilson disease. Hum Mol Genet (1993) 1.02
Resting energy expenditure is increased in infants and children with extrahepatic biliary atresia. J Pediatr Surg (1989) 1.01
Activation of transforming potential of the human insulin receptor gene. Proc Natl Acad Sci U S A (1987) 1.00
The association of cystic fibrosis, gastroesophageal reflux, and reduced pulmonary function. Can Assoc Radiol J (1988) 1.00